Ranking of Increasing Margin Buying Positions in Japan

About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.

Stock	Price	Change	Volume	Margin Ratio	Buy Positions(Shares)	Weekly Change	Market Cap	Liquidity
Globalway 3936 TSE Growth	176	-10 -5.4%	2,088,400	1,180.47	5,076,000	+2,401,700	6.44B	High
OncoTherapy Science 4564 TSE Growth	23	-1 -4.2%	179,113,400	7.64	20,477,300	+2,039,800	8.82B	Mid
Axelspace 402A TSE Growth	603	+9 +1.52%	1,736,500	0.00	9,151,500	+1,744,200	40B	High
BrightPath Biotherapeutics 4594 TSE Growth	59	+4 +7.27%	8,884,400	14.26	20,760,300	+1,414,900	8.19B	Slightly High
Environment Friendly Holdings 3777 TSE Growth	57	+1 +1.79%	1,833,500	0.00	22,252,400	+1,098,500	17.4B	Slightly High
3-D Matrix 7777 TSE Growth	503	-13 -2.5%	1,920,500	3,033.85	13,955,700	+1,025,300	64.4B	High
Def consulting 4833 TSE Growth	62	-1 -1.6%	641,500	0.00	12,464,000	+718,100	4.5B	High
MEDINET 2370 TSE Growth	28	0 ー%	240,900	0.00	13,161,900	+678,500	7.77B	Mid
Modalis Therapeutics 4883 TSE Growth	66	-14 -18%	14,371,300	0.00	10,974,900	+657,900	6.1B	Mid
jig.jp 5244 TSE Growth	257	+3 +1.18%	331,800	83.19	4,533,600	+530,800	10.9B	Mid
Convano 6574 TSE Growth	102	+3 +3.03%	815,000	0.00	13,859,700	+509,000	51.9B	High
STELLA PHARMA 4888 TSE Growth	525	+11 +2.14%	631,800	0.00	2,853,200	+482,100	18.4B	High
PLAID 4165 TSE Growth	535	+6 +1.13%	312,700	4.60	3,468,200	+445,500	22.1B	High
AnGes 4563 TSE Growth	54	+2 +3.85%	3,984,900	17.10	23,792,400	+438,800	21.4B	Slightly High
ACSL 6232 TSE Growth	2,502	+143 +6.06%	11,766,500	1.43	1,769,500	+419,400	47.9B	High
Chordia Therapeutics 190A TSE Growth	154	+4 +2.67%	1,434,100	0.00	6,243,600	+388,700	11.6B	Slightly High
HEALIOS 4593 TSE Growth	333	+18 +5.71%	1,475,500	14.34	11,338,800	+385,600	45B	High
Kubota Pharma 4596 TSE Growth	93	+1 +1.09%	948,700	0.00	6,205,900	+347,400	12.9B	High
BASE Inc 4477 TSE Growth	288	+2 +0.70%	1,211,100	38.87	25,470,000	+331,700	34B	Slightly High
ENECHANGE 4169 TSE Growth	331	+24 +7.82%	1,583,900	5.90	5,120,000	+290,100	14.2B	Slightly High

About:

Liquidity

Liquidity Grade

Liquidity	1-Year Average Number of Trades	Distribution
High	Over 1,000	13.9%
Slightly-High	400 to 1,000	18.5%
Mid	50 to 400	39.0%
Slightly-Low	10 to 50	17.6%
Low	Less than 10	11.0%

Labels